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Abstract
Loss of excitatory amino acid transporters (EAATs) has been implicated in a number of human diseases including
spinocerebellar ataxias, Alzhiemer’s disease and motor neuron disease. EAAT4 and GLAST/EAAT1 are the two predominant
EAATs responsible for maintaining low extracellular glutamate levels and preventing neurotoxicity in the cerebellum, the
brain region essential for motor control. Here using genetically modified mice we identify new critical roles for EAAT4 and
GLAST/EAAT1 as modulators of Purkinje cell (PC) spontaneous firing patterns. We show high EAAT4 levels, by limiting
mGluR1 signalling, are essential in constraining inherently heterogeneous firing of zebrin-positive PCs. Moreover mGluR1
antagonists were found to restore regular spontaneous PC activity and motor behaviour in EAAT4 knockout mice. In contrast,
GLAST/EAAT1 expression is required to sustain normal spontaneous simple spike activity in low EAAT4 expressing (zebrin-
negative) PCs by restricting NMDA receptor activation. Blockade of NMDA receptor activity restores spontaneous activity in
zebrin-negative PCs of GLAST knockout mice and furthermore alleviates motor deficits. In addition both transporters have
differential effects on PC survival, with zebrin-negative PCs more vulnerable to loss of GLAST/EAAT1 and zebrin-positive PCs
more vulnerable to loss of EAAT4. These findings reveal that glutamate transporter dysfunction through elevated extracellu-
lar glutamate and the aberrant activation of extrasynaptic receptors can disrupt cerebellar output by altering spontaneous PC
firing. This expands our understanding of disease mechanisms in cerebellar ataxias and establishes EAATs as targets for re-
storing homeostasis in a variety of neurological diseases where altered cerebellar output is now thought to play a key role in
pathogenesis.
†
These authors contributed equally to the work.
Received: March 21, 2018. Revised: April 30, 2018. Accepted: May 1, 2018
VC The Author(s) 2018. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
2614
Human Molecular Genetics, 2018, Vol. 27, No. 15 2614–2627
doi: 10.1093/hmg/ddy169
Advance Access Publication Date: 8 May 2018
Original Article
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/article-abstract/27/15/2614/4993965 by H
eriot W
att U
niversity user on 25 O
ctober 2018
Introduction
Excitatory amino acid transporter 4 (EAAT4) and GLAST/EAAT1
(rodent/human nomenclature) are members of a family of five
sodium-dependent plasma membrane glutamate transporters
(EAATs) (1) and are the major glutamate transporters in the cer-
ebellum, the region of the brain essential for maintaining pos-
tural control and coordination of voluntary muscle movement
(2). Various studies have implicated loss of EAAT4 and/or GLAST/
EAAT1 in the pathogenesis of several disorders affecting the motor
system including several subtypes of spinocerebellar ataxia (SCA),
SCA1 (3,4), SCA5 (5–7), SCA7 (8), episodic ataxia type 6 (9–11), spinal
muscular atrophy (12) and fragile X associated tremor/ataxia syn-
drome (13). Furthermore, disrupted GLAST/EAAT1 function has
been associated with schizophrenia (14,15) and cerebellar dysfunc-
tion is now also being linked to the pathophysiology of Alzheimer’s
disease (16,17), autism (18–20) and other cognitive and neuropsy-
chiatric disorders (21–23).
EAATs are responsible for the maintenance of low extracel-
lular glutamate levels which prevents neurotoxicity whilst en-
suring accurate synaptic communication (1). However, the full
detail of the pathogenic effects of transporter loss in disease
states is not yet clear and evidence is lacking for a primary role
of EAAT4 loss in cerebellar ataxia.
EAAT4 is expressed in Purkinje cells (PCs) (24), the principal
neurons and sole output of the cerebellar cortex, whereas
GLAST/EAAT1 is the predominant glial transporter, being
expressed in Bergmann glia 6-fold more abundantly than GLT-
1/EAAT2 (25). GLAST/EAAT1 is believed to be present uniformly
throughout the cerebellum in functional excess (26). In contrast,
EAAT4 displays a differential pattern of expression within para-
sagittal bands, mapping onto that of aldolase C (zebrin II), with
zebrin-positive (Zþ) PCs expressing EAAT4 to a much higher
level than zebrin-negative (Z–) PCs (27,28). This variable EAAT4
density has been shown to have synaptic physiological conse-
quences with larger glial AMPAR-mediated current amplitudes
observed in regions where PCs have lower endogenous levels of
EAAT4 (29) and the synaptic activation of mGluR1a, which
exhibits the same peri-synaptic distribution as EAAT4 (28,30),
found to be dampened in regions of high EAAT4 expression de-
spite no differential expression of mGluR1a (31). This physiolog-
ical effect of EAAT density on synaptic activity is due to the
slow glutamate translocation time of EAATs with multiple
cycles of transport not effective in the rapid removal of gluta-
mate from the synaptic cleft (32). Instead it is the density of
EAATs that governs the rapidity of binding and sequestration of
glutamate after synaptic release (33).
PCs, in addition to receiving excitatory and inhibitory synap-
tic input, also exhibit spontaneous high frequency repetitive fir-
ing (34,35), the frequency of which was recently reported to vary
between Zþ and Z– bands of the cerebellar cortex in rats (36)
and mice (37). To investigate whether a pathological loss of
EAAT4 and GLAST/EAAT1 protein has an effect on the sponta-
neous activity of PCs, and whether such a defect plays a key role
in the pathogenesis of cerebellar ataxia, we performed whole-
cell patch clamp recordings of PCs in vitro in EAAT4 (ET4–/–) and
GLAST (GLAST–/–) knockout mice. Here, we report that loss of
EAAT4 enhances the spontaneous firing frequency and
decreases the regularity of action potential firing of Zþ PCs by a
mechanism mediated through mGluR1 signalling. In contrast,
the intrinsic activity of Z– PCs is reduced in mice lacking GLAST
and this is mediated by NMDA receptor signalling. Motor defi-
cits arising from loss of EAAT4 and GLAST function are allevi-
ated by mGluR1 and NMDA receptor blockade, which restore
normal spontaneous simple spike activity in ET4–/– and
GLAST–/– knockout mice respectively. Furthermore, loss of
EAAT4 and GLAST results in loss of Zþ and Z– PCs, respectively.
Thus, this study demonstrates that within the cerebellum,
plasma membrane glutamate transporters have differential
roles in regulating the intrinsic firing frequency and survival of
PCs, both key elements in normal cerebellar function by ensur-
ing accurate and efficient processing of sensory information.
These data refine our understanding of how glutamate trans-
porter dysfunction can disrupt the encoding of information
within discrete functional units and contribute to disease path-
ogenesis in cerebellar disorders.
Results
Differential effect of cerebellar transporter loss on the
spontaneous firing frequency of PCs
To elucidate what effect reduced levels of the two predominant
cerebellar glutamate transporters have on the intrinsic proper-
ties and spontaneous firing pattern of PCs, we carried out
in vitro whole-cell patch clamp recordings on PCs from ET4–/–
and GLAST–/– mice. All recordings were carried out in the pres-
ence of AMPA and GABAA receptor antagonists to block fast syn-
aptic inputs. This revealed heterogeneity within the pattern of
spontaneous simple spike activity (Fig. 1A and B). All wild-type
PCs possessed a regular (tonic) rate of action potential firing, but
30% of PCs in ET4–/– mice were observed to fire irregularly with
periods of high frequency activity (bursting), although regular
tonic firing could be restored in all bursting cells by delivery of a
negative current. The regularity of simple spike activity was
quantified by calculating the coefficient of variation of inter-
spike interval (CV ISI) with a value >1 indicating high variance/
irregularity (Fig. 1C) and used to classify whether a PC was burst
firing. In contrast, 34% of PCs in GLAST–/– mice were found to be
silent with no spontaneous action potential firing recorded
within a minimum of 2 min. However, action potentials could
be elicited in all silent cells by a depolarizing current step. The
remaining PCs in ET4–/– and GLAST–/– mice (70 and 66%, respec-
tively) exhibited tonic firing with a CV ISI< 1.
EAAT4modulates the firing pattern of zebrin II positive
(Zþ) PCs whereas GLAST modulates the firing pattern of
zebrin II negative (Z–) PCs
Given EAAT4 expression levels differ through the cerebellum
(27,28), we next determined whether the heterogeneity in firing
observed in ET4–/– and GLAST–/– knockout mice correlated with
EAAT4 expression profile. This was achieved by creating ET4–/–-
eGFP and GLAST–/–-eGFP mice by crossing ET4–/– and GLAST–/–
mice with a fluorescent reporter BAC mouse (eGFP) in which
eGFP cDNA is under the control of the EAAT4 promoter (38).
To confirm the fluorescent intensity of GFP accurately reflects
EAAT4 promoter activity, we first visualized mid-sagittal cerebel-
lar sections from eGFP reporter mice. This revealed a higher GFP
signal in posterior lobules VI–X compared with anterior lobules I–
V (Fig. 2A) consistent with the fact EAAT4 expression is higher in
posterior lobules. Next, coronal cerebellar sections from eGFP re-
porter mice were immunostained using antibodies against either
EAAT4 or aldolase C (zebrin II), a protein known to exhibit the
same para-sagittal banding pattern as EAAT4 (28). In both instan-
ces, the immunoreactivity was identical to that of the eGFP band-
ing pattern (Fig. 2A), confirming that the eGFP fluorescence signal
does accurately reflect EAAT4 expression profile and can be used
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to visually distinguish Zþ and Z– PC subtypes. Of note no differ-
ence in EAAT4, GLAST or GLT1 levels were observed between WT
and WT-eGFP mice and neither full-length nor any truncated
form of EAAT4 protein was detected in the cerebellum of ET4–/–-
eGFP mice (Fig. 2B).
Having confirmed the fluorescent intensity of GFP accurately
distinguishes PC subtypes, whole-cell patch clamp recordings
were performed on either high GFP (Zþ) or low GFP (Z–) express-
ing PCs in 6-week-old WT-eGFP, ET4–/–-eGFP and GLAST–/–-eGFP
mice. This revealed that all ET4–/– PCs exhibiting irregular burst
firing (CV ISI> 1) were high GFP expressing (Zþ) cells (Fig. 2C and
D), whereas the regular spontaneous activity of low GFP express-
ing (Z–) ET4–/– cells was not significantly different to that of WT
cells (Z– WT, 41.663.9 Hz; Z– ET4–/–, 48.662.7 Hz; P¼ 0.66; Fig. 2C–
E). In contrast, the majority of silent PCs in GLAST–/– animals
were low GFP (Z–) expressing cells and thus were PCs with low
levels of EAAT4 protein (Fig. 2C). High GFP (Zþ) expressing cells in
GLAST–/– mice were all observed to have a similar spontaneous
intrinsic simple spike activity to that of WT cells (ZþWT,
39.86 4.3 Hz; ZþGLAST–/–, 41.168.3 Hz; P¼ 0.994; Fig. 2E).
Finally, although not all high GFP expressing (Zþ) ET4–/– cells
were found to be bursting (CV ISI> 1) they exhibited a signifi-
cantly higher tonic firing frequency (64.569.4 Hz; P¼ 0.047) to
that of Zþ WT cells (39.86 4.3 Hz). Conversely, all the low GFP
expressing (Z–) GLAST–/– cells that were not silent were signifi-
cantly less active, exhibiting a much lower firing frequency
(9.66 3.8 Hz; P¼ 0.001) to that of Z– WT cells (41.66 3.9 Hz;
Fig. 2E). Of note in 6-week-old WT animals a slightly higher fir-
ing frequency was detected in Z– WT cells compared with Zþ
WT cells but a significant increase in firing rate was only ob-
served in mice older than 3 months (Zþ 34.562.9 Hz, n¼ 12; Z–
53.467.5 Hz, n¼ 9; P¼ 0.04), an age similar to that used by Zhou
and colleagues (37).
mGluR1 activation downstream of EAAT4 loss mediates
irregular firing of ZþPCs
To test whether an acute loss of transporter activity can alter
spontaneous PC activity similar to a constitutive loss, WT cere-
bellar slices were pre-incubated with DL-TBOA (100 lM), a nonse-
lective glutamate transporter antagonist prior to performing
in vitro whole cell patch recordings. A concentration of 100 lM
TBOA was chosen as it blocks a significant proportion of, but
not all, transporter molecules and results in a physiologically
relevant increase in ambient glutamate (39). Following pre-
incubation for 1 h, the majority of PCs were found to exhibit an
irregular pattern of firing (CV ISI 3.7561.67; Fig. 3), similar to
that of high GFP expressing (Zþ) ET4–/– cells (2.960.8; Fig. 2C
and D). If incubation with DL-TBOA was extended to 2 h, further
elevating ambient glutamate levels, then the majority of PCs
were found to fall silent (Fig. 3A and C), with those not silent
possessing a regular but lower frequency of firing
(18.86 1.04 Hz; CV ISI 0.0660.005; Fig. 3B). The pre-incubation
with DL-TBOA was not pathological as normal tonic firing could
be restored in all silent cells with a depolarizing current step.
Next we investigated the effect a group 1 mGluR agonist,
dihydroxyphenylglycine (DHPG), had on the intrinsic firing
properties of Zþ WT PCs. This pharmacological manipulation
was carried out because regional differences in synaptic
mGluR1a activity have been shown to correlate with the ex-
pression pattern of EAAT4 (31) and mGluR1 agonists were
shown to induce burst activity in cultured Purkinje neurons
(40). Excessive mGluR activation induced by the application of
DHPG resulted in the irregular spontaneous firing of Zþ WT
PCs (CV ISI 8.861.5) but which was reversible following drug
wash-out (Fig. 4A and B). Moreover, the TBOA-induced burst-
ing phenotype in WT PCs was blocked in all but one cell by the
co-incubation of TBOA for 1 h with the mGluR1 antagonist
Figure 1. Different modes of intrinsic PC firing in EAAT4 and GLAST knockout mice. (A) Sample tonic, bursting and silent traces of PC current clamp recordings. (B)
Ratio of WT (N¼ 5, n¼26), ET4–/– (N¼ 6, n¼48) and GLAST–/– (N¼4, n¼23) PCs that fire tonically, burst fire or are silent. (C) Coefficient of variation of ISI for WT, ET4–/–
and GLAST–/– cells. Dotted line depicts CV¼1.
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CPCCOEt (10 lM). The restoration of normal tonic firing by
CPCCOEt (26.86 5.5 Hz; CV ISI 0.146 0.07) indicates that aber-
rant mGluR1 signalling was responsible for the irregular PC
firing following elevated ambient glutamate levels (Fig. 4B
and C).
NMDA receptor activation downstream of GLAST loss
abolishes Z– PC spontaneous activity
Depolarization-induced potentiation of inhibition has been
reported in the cerebellum whereby activation of pre-synaptic
NMDA (ionotropic glutamate) receptors on molecular layer
Figure 2. Modes of intrinsic PC firing correlate with differential expression profiles of EAAT4. (A) Left, mid-sagittal cerebellar section from a fluorescent reporter BAC
mouse in which eGFP (green) cDNA is under the control of the EAAT4 promoter. Bar, 500 mm. Right, coronal cerebellar sections from WT-eGFP (green) reporter mouse
immunostained for either aldolase C (red) or EAAT4 (red). Bar, 50mm. (B) Immunoblot analyses of EAAT protein levels in cerebellar homogenates from WT, WT-eGFP
and ET4–/–-eGFP mice. (C) Ratio of high GFP (Zþ) and low GFP (Z–) expressing PCs in WT-eGFP (n¼35), ET4–/–-eGFP (n¼33) and GLAST–/–-eGFP (n¼16) mice that fire toni-
cally, burst fire or are silent. (D) Coefficient of variation of ISI for WT-eGFP and ET4–/–-eGFP PCs. Dotted line depicts CV¼1. (E) Spontaneous firing frequency of high GFP
(Zþ) and low GFP (Z–) expressing PCs in WT-eGFP, ET4–/–-eGFP and GLAST–/–-eGFP mice. Mean6SEM.
Figure 3. Acute elevations to extracellular glutamate levels alters spontaneous WT PC firing patterns. (A) Sample trace of WT PC and cells incubated with TBOA. (B)
Coefficient of variation of ISI for WT PCs following pre-incubation with either vehicle (N¼3, n¼ 16) or TBOA (N¼3, n¼10). Dotted line depicts CV¼1. (C) Ratio of WT
PCs that are tonically firing, bursting or are silent following pharmacological treatment to elevate extracellular glutamate levels.
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interneuron terminals results in a sustained increase in inhibi-
tory efficacy onto PCs (41). Furthermore, glial glutamate trans-
porters have been shown to influence synaptic inhibition of PCs
by limiting glutamate spillover and hence the activation of pre-
synaptic NMDA receptors (42). At 6 weeks of age PCs are not be-
lieved to express functional NMDA receptors (43). We therefore
determined whether excessive presynaptic NMDA activation
could be responsible for the silencing of Z– PCs in GLAST–/– mice
due to glutamate spillover in regions of the cerebellar cortex
with low EAAT4 levels. This was achieved by pre-incubating
acute cerebellar slices from GLAST–/–-eGFP mice with AP5
(50lM), an NMDA receptor antagonist, for 30 min prior to per-
forming whole cell patch recordings. Following NMDA receptor
blockade all Z– PCs in GLAST–/– mice were no longer silent, but
were found to be spontaneously active (21.263.9 Hz; CV ISI
0.1560.04; N¼ 3, n¼ 8; Fig. 5A and B), in contrast to control sli-
ces where all silent PCs remained silent (N¼ 3, n¼ 13). We then
investigated whether NMDA receptor blockade could rescue
motor deficits in GLAST deficient mice by administering AP5
(2.5 mg/kg). The ability of animals to stay on the rotarod at
10 rpm following drug administration was compared with their
pre-treatment performance (Fig. 5C). This revealed a significant
improvement in motor performance following administration
of AP5 (51.76 10.5 s) compared with vehicle (19.464.3 ;
P¼ 0.0096 paired t-test; N¼ 5). There was no adverse effect of
AP5 treatment on the motor behaviour of wild-type animals (ve-
hicle, 120 s; AP5, 118.561.5 s; P¼ 0.391 paired t-test; N¼ 4).
A similar effect on Z– PC spontaneous activity was observed
with age. In 1-year-old WT mice 45.5% of PCs from the predomi-
nantly Z– anterior lobules (I–V) were found to be silent whereas
only 8.3% of cells were silent in the predominantly Zþ posterior
lobules (VIII–X) (N¼ 3, n¼ 22, lobules I–V; N¼ 5, n¼ 36, lobules
VIII–X; P¼ 0.0023; Fig. 5C). This is in contrast to all Zþ and Z–
PCs in young mice exhibiting regular spontaneous activity
(Fig. 2C). A significant reduction in GLAST protein levels was ob-
served in 1-year-old compared with 1-month-old WT mice
(65.36 1.9% of 1-month-old levels, N¼ 4, P¼ 0.0004; Fig. 5D) indi-
cating the loss of GLAST protein could be a factor of age-
associated silencing of Z– PCs and in turn age-related motor de-
cline. These findings are also consistent with our previous study
in a disease model of SCA type 5 where one third of in vivo PC
recordings from lobule V in 8-month-old b-III–/– mice exhibited
no simple spike firing (5). At this age b-III–/– mice have a signifi-
cant reduction in GLAST protein (5) supporting the case that
Figure 4. mGluR1 activation gives rise to irregular spontaneous WT PC firing. (A) Sample trace of WT PC in the presence and absence of DHPG (50lM). (B) Coefficient of
variation of ISI for WT PCs following application of DHPG (N¼ 4, n¼9) or pre-incubation with 10 lM CPCCOEt and 100lM TBOA (n¼7). Dotted line depicts CV¼1.
(C) Ratio of WT PCs that are tonically firing or bursting following pharmacological treatment to manipulate mGluR1 signalling.
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loss of GLAST function results in a decrease in PC activity and
reduced output from the anterior cerebellar cortex.
Differential effect of cerebellar transporter loss on PC
survival
Next we asked whether there was any regional difference in PC
survival in ET4–/– and GLAST–/– animals. In mid-sagittal sections
we found no difference in thickness of molecular layer between
1-year-old WT, ET4–/– and GLAST–/– animals (WT, 1246 2.9; ET4–/–,
122.86 4.4; GLAST–/–, 121.26 3.8lm, N¼ 5) but a loss of PCs was
observed in the anterior lobules of 1-year-old GLAST–/– animals
(P¼ 0.045) and in the posterior lobules of 1-year-old ET4–/– mice
(P¼ 0.04; Fig. 6A and B). In contrast, no PC loss was observed in ei-
ther anterior or posterior lobules of 6-week-old ET4–/– and
GLAST–/– animals (anterior ET4–/– 106.76 1.6, GLAST–/– 97.66 2.1,
posterior ET4–/– 104.36 1.3, GLAST–/– 102.663.4% of WT). Upon
examination of coronal sections from 1-year-old ET4–/–-GFP and
GLAST–/–-GFP mice significant differences between high GFP
expressing (Zþ) and low GFP expressing (Z–) PCs was evident,
with high and low GFP expressing PCs differentially lost in ET4–/–-
GFP (posterior P¼ 0.005) and GLAST–/–-GFP mice (anterior
P¼ 0.000079; posterior P¼ 0.001), respectively (Fig. 6C and D). In
the case of GLAST–/–-GFP mice, the most profound loss of low GFP
expressing PCs was out with the central vermis.
EAAT4 knockout mice display progressive ataxia
Because this study revealed Zþ PCs in ET4–/– mice exhibit irregu-
lar spontaneous intrinsic activity and with age there is loss of
Zþ PCs, combined with previous studies that reveal EAAT4 loss
affects synaptic events (7,44,45), we carried out a longitudinal
behaviour analysis of ET4–/– mice to determine whether they ex-
hibit any motor deficits. This involved carrying out gait analysis,
rotarod and an elevated beam task on 6-week, 6-month and 10-
month-old WT and ET4–/– animals.
Young ET4–/– animals (6 weeks of age) were significantly
worse than WTs, on all four days of testing (P¼ 0.032, 0.016,
0.02, 0.01, days 1–4, respectively) when the speed of rotarod was
10-rpm, but not when tested at 3- or 5-rpm (Fig. 7A). Motor defi-
cits in ET4–/– animals were also found to be progressive as at 6
weeks of age, there was no difference in number of slips off the
elevated beam (P¼ 0.996; Fig. 7B) or hind-limb base width
(P¼ 0.997; Fig. 7C) but by 6 months of age ET4–/– animals made
more slips on the elevated beam (WT, 0.2760.19; ET4–/–,
1.760.33, P¼ 0.0001; Fig. 7B), had a wider hindlimb base width
(WT, 2.1860.1; ET4–/–, 2.486 0.06 cm, P¼ 0.025; Fig. 7C) and by 10
months of age they were significantly worse on the rotarod at
5 rpm compared with age-matched WT animals on all days of
testing (P¼ 0.006, 0.032, 0.035, 0.035, day 1–4, respectively;
Fig. 7D).
mGluR1 blockade restores regular PC firing and
alleviates motor deficits in ET4–/– mice
To test if mGluR1 blockade could restore regular firing in ET4–/–
mice, as was seen for the TBOA-induced bursting phenotype in
WT PCs (Fig. 4A and B), acute cerebellar slices were pre-
incubated with mGluR1 antagonists for 30 min prior to perform-
ing whole cell patch recordings. The irregular firing observed in
Figure 5. NMDA receptor blockade restores spontaneous PC firing in GLAST–/– PCs and alleviates motor deficits. (A) Sample traces of Z– GLAST–/– PCs pre-incubated
with vehicle and with AP5 (50lM). (B) Ratio of GLAST–/– PCs that are silent or tonically firing following pharmacological treatment to block NMDA receptor activation.
(C) Schematic of drug treatment paradigm and latency of GLAST animals to fall from rotarod at 10-rpm. Data following vehicle administration and 2.5 mg/kg AP5 is
plotted for each animal, alongside the cohort mean6SEM. (D) Ratio of modes of intrinsic activity in PCs from Z– and Zþ lobules in 1-year-old WT animals.
(E) Immunoblot analyses of GLAST protein levels in cerebellar homogenates from 1-month and 1-year-old WT animals.
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high GFP expressing (Zþ) ET4–/– cells was abolished and tonic
firing restored by both CPCCOEt (28.562.6 Hz; CV ISI 0.146 0.03)
and JNJ16259685 (32.06 3.8 Hz; CV ISI 0.1060.01), a selective and
systemically active mGluR1 antagonist (Fig. 8A and B). Similarly
pre-treatment with thapsigargin (2 mM), a Ca2þ-ATPase inhibitor,
to deplete IP3-gated Ca
2þ stores restored tonic firing in ET4–/–
Zþ cells (2664.2 Hz; CV ISI 0.116 0.02).
Next we investigated whether mGluR1 blockade could res-
cue the motor deficits observed in 6-week-old ET4–/– mice by ad-
ministering JNJ16259685 (0.15 mg/kg) (Fig. 8C and D). The ability
of animals to stay on the rotarod at 10 rpm, the only motor task
found to be impaired in young ET4–/– mice, following drug ad-
ministration was compared with their pre-treatment perfor-
mance (Fig. 8D). This revealed a significant improvement in
motor performance following administration of JNJ16259685
(93.76 8.5 s) compared with vehicle (65.76 6.5 s; P¼ 0.007 paired
t-test; N¼ 15). No adverse effect of JNJ16259685 treatment was
observed on rotarod performance of wild-type animals
(118.36 1.1 s; P¼ 0.724) but mice lacking GLAST were further
impaired on the rotarod following administration of
JNJ16259685 (5.962.3 s; P¼ 0.011). Together the data indicate
mGluR1 blockade can alleviate motor deficits resulting from
loss of EAAT4, but not that of GLAST.
Discussion
The pathogenic consequences of cerebellar glutamate trans-
porter dysfunction have, to date, been largely related to excito-
toxicity. Here we demonstrate for the first time that the two
predominant cerebellar glutamate transporters, EAAT4 and
GLAST/EAAT1, have critical but differential roles in the modula-
tion of spontaneous PC firing patterns. This study expands our
understanding of how glutamate transporter dysfunction
through elevated extracellular glutamate and the dysregulation
of peri- and extra-synaptic receptors, as well as receptors on
nearby cells, contributes to disease pathogenesis in cerebellar
disorders. Of note the study also highlights that in disease
states the effect on cerebellar cortical output from specific PC
Figure 6. PC loss correlates with differential expression profile of EAAT4. (A) Representative confocal images of regions in lobule III and lobule IX from 1-year-old WT,
ET4–/– and GLAST–/– mice. Midline sagittal cerebellar sections were immunostained with anti-ITPR1 antibody. Bar, 50 mm. (B) Quantification of anterior and posterior PC
density in 1-year-old WT (N¼5), ET4–/– (N¼3) and GLAST–/– (N¼4) mice. (C) Representative images of regions from anterior and posterior coronal sections from 1-year-
old ET4–/–-GFP and GLAST–/–-GFP mice with arrows indicating PC loss. Bar, 50mm. (D) Quantification of posterior and anterior Z– and Zþ PC density in 1-year-old ET4–/–-
GFP and GLAST–/–-GFP mice (N¼4). All data are means6SEM.
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populations and hence inhibition onto neurons in the cerebellar
nuclei will differ depending on the EAAT dysfunction. High lev-
els of EAAT4 protein are required to constrain the inherent ex-
citability and plasticity of Zþ PCs by limiting mGluR1 signalling.
In contrast GLAST/EAAT1 appears to play no role in modulating
the firing pattern of the Zþ subpopulation of PCs but it does
have a fundamental role in sustaining normal spontaneous
simple spike activity in low EAAT4 expressing (Z–) PCs by pre-
venting NMDA receptor activation. Loss of GLAST from these
regions of the cerebellum results in a substantial decrease in
spontaneous activity of Z– PCs, with the majority falling silent
and the other Z– cells exhibiting a very low intrinsic firing fre-
quency. In addition, both these cerebellar transporters were
found to have differential effects on PC survival, with EAAT4 ex-
pression important in preventing Zþ PC death in the posterior
cerebellum, whereas GLAST expression is required for the long-
term survival of PCs expressing low levels of EAAT4. Together
the data provide strong evidence that the consequence of
GLAST/EAAT1 or EAAT4 loss varies between cerebellar regions,
but in both cases it has a profound effect on intrinsic properties
of PCs, cell survival and motor coordination. This new knowl-
edge that ambient elevations in extracellular glutamate due to
glutamate transporter dysfunction can alter the spontaneous
firing pattern of PCs contributes to a better understanding of
disease mechanisms.
Loss of EAAT4 results in ataxia and selective PC death
Here we show for the first time that loss of EAAT4 results in an
ataxic phenotype and that the motor deficits are progressive.
Although it has previously been reported that EAAT4 knockout
mice do not have a cerebellar phenotype, this observation was
simply based on a visual inspection of cage behaviour (46).
Without direct assessment of motor task function motor deficits
are likely to be overlooked; indeed given the young age of ET4–/–
mice studied it is also possible that the visual observation of
cage behaviour was not carried out on sufficiently aged ET4–/–
animals (46).
This study is also the first to implicate loss of EAAT4 in PC
death and specifically of Zþ cells in the posterior cerebellum.
Previous studies using ET4–/– mice either did not look (44,45)
or analysis was not carried out on aged animals (47).
Furthermore in the latter study using 8- to 12-week-old mice
PC density was only quantified within the anterior cerebellum
(lobule III) and not posterior lobules. The authors report PC
loss following brain ischemia in lobule III of GLAST knockout
mice but not EAAT4 knockout mice (47). This is in agreement
with our findings but we also find that low EAAT4 expressing
PCs in the posterior cerebellum, especially out with the central
vermis, are vulnerable to cell death in the absence of GLAST
protein.
Figure 7. EAAT4 knockout mice exhibit progressive motor deficits. (A) Latency of 6-week-old animals to fall from rotarod at 3-, 5- and 10-rpm. (B) Number of hind-limb
slips made by 6-week and 6-month-old mice when crossing narrow, elevated beam. (C) Hind-limb base width of 6-week and 6-month-old animals. (D) Latency of 10-
month-old WT and ET4–/– animals to fall from rotarod at 3- and 5-rpm. N¼14 (6-week WT), 22 (6-week ET4–/–), 12 (6-month WT), 10 (6-month ET4–/–), 5 (10-month WT)
and 6 (10 month ET4–/–). All data are means6SEM.
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Therefore, in studies of ataxia where a loss of EAAT4 is ob-
served this can now be directly implicated in a motor pheno-
type, so contributing to a better understanding of mechanisms
that underpin cerebellar ataxia. The defects in cerebellar corti-
cal output would likely arise from a combination of effects fol-
lowing EAAT4 loss; notably the findings reported here that Zþ
PCs in the posterior cerebellum exhibit irregular firing patterns
due to aberrant mGluR1 signalling and altered intrinsic proper-
ties and that they are more vulnerable to cell death following
EAAT4 loss but also that EAAT4 loss affects synaptic events, al-
tering the size and/or duration of excitatory postsynaptic cur-
rents at parallel fibre-PC synapses (7,44,45) and impairing the
clearance of released glutamate at climbing fibre-PC synapses
(46,48,49). Of note the latter defect is confounded by the fact
that greater glutamate release was shown to occur from climb-
ing fibre terminals in zebrin-positive regions (50).
Intrinsic ZþPC membrane firing pattern is regulated by
EAAT4 and mediated by mGluR1 signalling
Our data suggest that the irregular firing of Zþ PCs and motor
incoordination resulting from EAAT4 loss are mediated by
mGluR1 signalling. This is consistent with other recent studies
that have implicated dysregulated mGluR1 signalling in altered
PC excitability and ataxia. For example, prolonged mGluR1 ac-
tivity at cerebellar parallel fibre–PC synapses was observed in
moderately ataxic SCA1 mice (51) and mGluR1 activation was
also shown to increase intrinsic PC firing in cerebellar slices
from SCA2 mice (52). Moreover, consistent with our findings in
regard to mGluR1 antagonist improvement in motor perfor-
mance in ET4–/– mice, studies show that modulating mGluR1 ac-
tivity and glutamatergic stimulation can restore motor
performance in other mouse models of ataxia (51,53). Removing
excessive mGluR1 activity by treating with JNJ16259685 im-
proved motor performance in young SCA1 (51) but not old SCA1
mice (54). This difference in response to mGluR1 modulation
may be due to the subsequent loss of GLAST in later stages of
disease in SCA1 mice (4) as we find that mGluR1 blockade fur-
ther impairs motor performance in mice lacking GLAST. In
SCA28 mice reducing mGluR1 expression or increasing EAAT2
expression does alleviate ataxia (53). Of note, intrinsic excitabil-
ity of wild-type PCs was found to be increased following induc-
tion of long-term depression in the parallel fibre-PC synapses
(55), an event dependent on mGluR1 activity (56).
Currently it is unclear what downstream PC dendritic ionic
conductance(s) are affected and responsible for the changes in
neuronal firing observed in this study. However, deciphering
the complex interplay of metabotropically regulated currents
will be essential in elucidating the downstream cellular mecha-
nisms that underpin alterations to PC intrinsic properties and
which contribute to aberrant cerebellar output in disease states.
Possibilities include the activation of low-threshold T-type cal-
cium channels (57), changes to the surface expression of HCN
channels, regulated by PLCb/IP3R and protein kinase C activities
(58), or differences in potassium channels some of which have
been implicated in ataxia (59–62). Whether the differential ex-
pression of isoforms of mGluR1 (63), PLC beta (64) or other
downstream signalling molecules such as aCaMKII are impor-
tant in the regional effects mediated by the expression profile of
cerebellar EAATs remains to be elucidated. Given mGluR1b does
not interact with homer proteins (65) and is complementary to
zebrin II (63), hence EAAT4, it could be that differences in the
postsynaptic effectors of homer-dependent and homer-
independent mGluR1 isoforms are relevant in the differential
Figure 8. mGluR1 blockade restores regular PC firing and alleviates motor deficits in ET4–/– mice. (A) Sample traces of Zþ ET4–/– PCs pre-incubated with vehicle and with
10lM CPCCOEt. (B) Coefficient of variation of ISI for ET4–/– PCs following pre-incubation with either vehicle (n¼18), 10lM CPCCOEt (CPC, n¼16), 3 nM JNJ16259685 (JNJ,
n¼5) or 2 lM thapsigargin (Thaps, n¼15). Dotted line depicts CV¼1. (C) Schematic of drug treatment paradigm and latency of 6-week-old ET4–/– animals to fall from
rotarod at 10-rpm. Data following vehicle administration and 0.15 mg/kg JNJ16259685 is plotted for each animal, alongside the cohort mean6SEM.
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regulation of PC intrinsic properties within parasagittal com-
partments. For instance mGluR1a possesses higher affinity and
coupling efficacy to G proteins and phospholipase C than
mGluR1b (66). This would result in differences in Ca2þ release
from intracellular stores and may account for ZþPCs reacting
differently to that of Z– PCs following loss of EAAT function.
The differences in glutamate release (50) and calcium signalling
downstream of mGluR1a activation may also account for the
fact that the proximal dendrites, sites of climbing fibre innerva-
tion, are the first to degenerate in PCs from the posterior cere-
bellum of b-III–/– mice that lack functional EAAT4 (5,7).
In the future identifying all the proteins that underlie the
different physiological profiles of PC subpopulations will be key
to understanding the functional diversity of microzones within
the cerebellar cortex and how distinct changes to firing patterns
occur in different disease states.
Modulation of Z– PC intrinsic properties by GLAST/
EAAT1 activity as a potential factor in neurological
disorders
Physiological defects have been reported to occur from changes
to GLAST/EAAT1 activity with GLAST knockout mice exhibiting
progressive motor incoordination (7,67) and mutations in
SLC1A3, the gene encoding EAAT1, being associated with epi-
sodic ataxia type 6 (EA6) (9–11). In the case of one EA6 point mu-
tation, substitution of proline 290 by an arginine, there is both
an abnormal chloride conductance and a decrease in glutamate
transport rates (9,68). A recent study in Drosophila proposes it is
excessive chloride extrusion by the mutant transporter that is
relevant to disease pathogenesis, as increased chloride uptake
rescues locomotor performance (69). It is proposed that changes
to intracellular chloride concentrations affect the osmotic bal-
ance, reduce cell volume and therefore ensheathment of synap-
ses by astrocytes (69). A recent study also reports a retraction of
Bergmann glial processes from PC dendrites in GLAST knockout
mice (70). Such a reduced glial coverage of synapses superim-
posed on loss of GLAST/EAAT1 would further facilitate gluta-
mate diffusion, extra-synaptic crosstalk and altered ionic
conductances within dendrites. Together these studies improve
our understanding of how PC dysfunction can arise following
loss of the glial glutamate transporter GLAST in regions where
EAAT4 levels are low. Given NMDA receptors composed of
GluN1/GluN2C and GluN1/GluN2D subunits are less sensitive to
Mg2þ block (71) it is likely that these are the molecular layer in-
terneuron receptor subtypes being activated by glutamate spill-
over. Furthermore as all recordings were performed in the
presence of picrotoxin, a GABAA receptor antagonist it is pro-
posed that aberrant dendritic GABAB receptor activation is in-
volved, providing insights into the cellular mechanisms
downstream of loss of GLAST function that underpin cerebellar
dysfunction. This is consistent with the finding that baclofen, a
GABAB agonist inhibits PC firing and that this inhibition persists
in the presence of a GABAA antagonist (72).
Conversely increased EAAT1 activity has been suggested to
be a factor in some neurodevelopmental disorders. A functional
SLC1A3 variant has been reported to be more prevalent in indi-
viduals with Tourette syndrome than controls and found to re-
sult in increased EAAT1 membrane insertion and glutamate
uptake (73). A gene duplication of SLC1A3 has also been reported
as a possible risk factor for autism and attention deficit/hyper-
activity disorder–like behaviour (74). The current study there-
fore points towards altered EAAT1 glutamate transport activity
being implicated in neurodevelopmental disorders by modulat-
ing dendritic ionic conductances and hence spontaneous PC ac-
tivity. In fact similar regional cerebellar differences to that
observed in GLAST–/– and ET4–/– mice have been reported in
Shank2-deficient mice that exhibit autism-like behaviour (75). A
significant decrease in simple spike frequency was observed in
anterior lobules of global Shank2–/– mice, but not in their poste-
rior lobules whereas a consistent irregularity of simple spikes
was observed in PCs from the posterior but not anterior lobe.
Depolarizing current steps have also revealed that PCs in the
posterior, but not the anterior, cerebellum of b-III–/– mice exhibit
increased membrane excitability compared with wild-type PCs
(data not shown) even though they display reduced spontane-
ous simple spike activity due to loss of ankyrin R and lower den-
sities of Nav1.1 and Nav1.6 (5,76). Similarly GLT1/EAAT2
dysfunction has been implicated in enhanced pyramidal neuro-
nal excitability in fragile X syndrome (77) and pathological re-
petitive behaviours (78). It therefore appears that alterations to
distinct physiological profiles and intrinsic activity of PCs within
microzones of the cerebellar cortex downstream of aberrant
EAAT activity impairs the correct processing and efficient trans-
mission of information possibly by decoupling coordinated acti-
vation of neighbouring functional microzones (79). Future
studies are needed to address how aberrant cerebellar EAAT ac-
tivity modulates intrinsic PC dendritic properties, not only in
disorders of the motor system, but also in autism spectrum dis-
orders and other cognitive and neuropsychiatric disorders given
the emerging role of cerebellar dysfunction in these disorders
(18–23).
To conclude, this study identifies a new and central role for
plasma membrane glutamate transporters in regulating sponta-
neous PC activity and survival, both key determinants of cere-
bellar output, by restricting the activation of peri- and extra-
synaptic receptors, as well as receptors on nearby cells.
Consequently altering functional cerebellar EAAT levels may
prove very effective in restoring dendritic ionic conductances
and neuronal function in a number of neurological disorders
where intrinsic neuronal excitability is altered.
Materials and Methods
Animals
All procedures involved in generation and analysis of mutant
mice were carried out according to the United Kingdom
Animals (Scientific Procedures) Act (1986) and other Home
Office regulations under specific-pathogen-free conditions.
GLAST–/– and ET4–/– mice, both on a C57BL/6 genetic back-
ground, were maintained and crossed with eGFP-reporter mice
to generate GLAST–/–-eGFP and ET4–/–-eGFP mice. The genotypes
of all animals were determined by PCR analysis on genomic
DNA extracted from ear notch biopsies using ChargeSwitch
gDNA tissue kit (Invitrogen, Carlsbad, CA) and both sexes were
used in all experiments. For ET4–/– mice a common upstream
primer (50-ttcctgattgctggaaagattctgg-30) and primers specific for
the wild-type allele (50-agttcagggaaaggccataccttgg-30) and the
PGK-neo cassette in the mutant allele (50-ggatcggccattgaacaa-
gatgg-30) were used for amplification at an annealing tempera-
ture of 57C. The 220-bp (from wild-type allele) and 1200-bp
(from targeted allele) PCR products were resolved by electropho-
resis on a 1.6% (w/v) agarose gel. For GLAST–/– mice the specific
primer sets used for amplification of wild-type allele were (50-
aagtgcctatccagtccaacga-30; 50-aagaactctctcagcgcttgcc-30) and
mutant allele (50-aatggaaggattggagctacgg-30; 50-ttccagttgaagg
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ctcctgtgg-30) at an annealing temperature of 54C. The 214-bp
(from wild-type allele) and 362-bp (from targeted allele) PCR
products were resolved by electrophoresis on a 1.6% (w/v) aga-
rose gel. The primer set specific for GFP was 50-aagttcatctgcac-
caccg-30and 50-tccttgaagaagatggtgcg-30and used at an annealing
temperature of 55C. The 220-bp GFP PCR product was resolved
by electrophoresis on a 1.6% (w/v) agarose gel. Immunoblot
analysis using polyclonal antibody against EAAT confirmed
ET4–/– genotype in ET4–/–-eGFP mice (presence of EAAT4-BAC
construct prevented detection of homozygosity by PCR). All
knockout mice were viable although pups from GLAST–/– and
GLAST–/–-eGFP mice were routinely fostered with CD1 mothers
to ensure survival.
Immunoblotting
Whole cerebella were homogenized in 400 ll of ice-cold homog-
enization buffer [20 mM HEPES, pH 7.4, 1 mM EDTA, 1 mM phe-
nylmethylsulfonyl fluoride and protease inhibitor cocktail
(Calbiochem, San Diego, CA)] with a Teflon-glass homogenizer.
Protein concentrations were determined using Coomassie-Plus
Reagent and bovine serum albumin as standard (Pierce,
Rockford, IL). Protein samples were resolved by denaturing SDS-
polyacrylamide gel electrophoresis and transferred to nitrocel-
lulose membranes (Amersham Pharmacia). The membranes
were blocked for 1 h at room temperature with 5% (w/v) non-fat
dry milk in Tris-buffered saline/Tween 20 [TBS/T, 20 mM Tris,
200 mM NaCl (pH 7.6) with 0.1% (v/v) Tween-20]. Blots were in-
cubated overnight at 4C with either rabbit anti-EAAT4, -GLAST
(1:200), -GLT1 (1:4000) (all from Jeffrey Rothstein), or mouse anti-
actin (1:1600; Sigma, St. Louis, MO) in blocking buffer. After
washing with TBS/T the blots were incubated for 1 h at room
temperature with either HRP-conjugated donkey anti-rabbit
IgG, or HRP-conjugated sheep anti-mouse IgG (1:4000;
Amersham Pharmacia). Immunoreactive proteins were visual-
ized with enhanced chemiluminescence (ECL, Santa Cruz
Insight Biotechnology, Wembley, UK).
Immunohistochemistry
Brains were removed and immersion-fixed with 4% (w/v) para-
formaldehyde in 0.1 M sodium phosphate buffer, pH 7.4 over-
night at 4C and cryoprotected by immersion in 0.1 M sodium
phosphate buffer (pH 7.4) containing 30% (w/v) sucrose. 30-lm-
thick coronal or mid-sagittal free-floating cerebellar sections
were incubated for at least 3 h with blocking solution [5% (v/v)
normal goat serum with 0.4% (v/v) Triton X-100 in PBS] prior to
applying rabbit anti-EAAT4, anti-aldolase C and anti-ITPR1 anti-
body (Millipore) [2% (v/v) normal goat serum/0.1% (v/v) Triton X-
100 in PBS] overnight at 4C. Sections were washed three times
in PBS before applying either Cyanine 3 (Cy3)-conjugated goat
anti-rabbit IgG (Jackson laboratories) or fluorescein isothiocya-
nate–conjugated goat anti-rabbit IgG (Cappel) for 1 h at room
temperature followed by three rinses in PBS and coverslipping
with Vectashield (Vector Laboratories, Burlingame, CA). All
quantification was carried out blind to genotype and involved
counting the number of PCs, along 1 mm linear lengths in ante-
rior (II–IV) and posterior (VIII–X) lobules from three sections/ani-
mal and the counts averaged for each animal. Images were
captured with either a Zeiss inverted LSM510 or Nikon confocal
laser scanning microscope in the IMPACT imaging facility,
Centre for Discovery Brain sciences. Colours were applied using
Image J.
Slice electrophysiology
Cerebella (from 6-week-old animals unless otherwise stated)
were dissected out into ice-cold modified artificial cerebrospinal
fluid (ACSF) containing (in mM): 60 NaCl, 118 sucrose, 26
NaHCO3, 2.5 KCl, 11 glucose, 1.3 MgCl2 and 1 NaH2PO4 at pH 7.4
when bubbled with 95% O2:5% CO2. The cerebellar vermis was
glued to the vibratome cutting platform (Leica VT 1200S,
Germany) with cyanoacrylate adhesive. About 200 mm-thick sag-
ittal slices cut from the central vermis were incubated for
30 min at 30C in standard ACSF composed of the following (in
mM): 119 NaCl, 2.5 CaCl2, 26 NaHCO3, 2.5 KCl, 11 glucose, 1.3
MgCl2 and 1 NaH2PO4 at pH 7.4 when bubbled with 95% O2:5%
CO2, followed by 1 or 2 h 100 lM TBOA (DL-threo-b-benzyloxyas-
partic acid), 30 min 10 lM CPCCOEt, 3 nM JNJ16259685, 2 lM thap-
sigargin, 50 lM AP5 or wash-in of 50 lM DHPG. Slices were
transferred to a submerged recording chamber and superfused
with standard ACSF (3–5 ml min1) at 32C with 10 lM NBQX and
50 lM picrotoxin to block AMPA and GABAA receptors,
respectively. PCs were visualized with a 40 immersion objec-
tive and Normarski differential interference contrast optics.
Whole-cell recordings were obtained from PCs using thick-
walled borosilicate glass pipettes with resistances of 3–5 MX.
The internal solution contained (in mM): 125 K-Gluconate,
15 KCl, 10 HEPES, 5 EGTA, 2 MgCl2, 0.4 NaGTP, 2 NaATP and
10 Na-phosphocreatine, adjusted to pH 7.4 with KOH. All PCs
showing spontaneous activity were routinely recorded for
5–10 min. For those cells that were silent or were burst firing
current was injected at least 2 min into the recording. Data were
acquired using pClamp 9 (Molecular Devices, Sunnyvale, CA) and
recordings were filtered at 2 kHz and sampled at 10 kHz. Data
analysis was carried out in Neuromatic, IGOR Pro (Wavemetrics,
Lake Oswego, OR) and using in-house MatLab scripts.
Motor coordination tests
Footprint patterns were analyzed using a runway (80 cm by
10.5 cm wide) with white paper at the bottom. Hind paws of
animals were dipped in non-toxic, water-soluble black ink
(Indian Ink, Winsor & Newton, Harrow, UK). Three consecutive
strides were measured for each animal and base width was
measured as the distance between the centre of one paw print
to the centre of the next print on the opposite side. The ele-
vated beam test was performed using a narrow horizontal
beam (2 cm wide, 80 cm long, held at a height of 30 cm from
the table). The number of hind paw slips the animal made
whilst traversing the beam were counted. In the rotarod test
the time a mouse remained on a rotating (3, 5 and 10 rpm) 3-
cm-diameter cylinder was recorded (maximum 120 s; four tri-
als per speed; TSE Rotarod, Bad Homburg, Germany). 6-week-
old ET4–/– mice received intraperitoneal injections of vehicle
(sterile saline with 10% (w/v) hydroxypropyl-betacyclodextrin)
30 min before rotarod testing. Two hours after completion of
rotarod testing, the same mice were injected with 0.15 mg/kg
JNJ16259685 (Tocris Bioscience) dissolved in vehicle.
Administration of JNJ at higher doses resulted in greater pas-
sivity, reduced rearing, a crouching behaviour and impaired
motivation. About 6-month-old GLAST deficient mice received
intraperitoneal injections of vehicle (sterile water) 30 min be-
fore rotarod testing. Two hours after completion of rotarod
testing, the same mice were injected with 2.5 mg/kg AP5
(Tocris Bioscience) dissolved in vehicle.
2624 | Human Molecular Genetics, 2018, Vol. 27, No. 15
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/article-abstract/27/15/2614/4993965 by H
eriot W
att U
niversity user on 25 O
ctober 2018
Statistics
Statistical analysis was carried out using SPSS v21 (SPSS Inc.,
Chicago, IL, USA). Analysis was performed using Student’s t-test
for two groups of data and one-way analysis of variance for
comparisons of three or more data groups. Contingency table
and Fisher’s tests were used for categorical data evaluation.
Significance was accepted at P-values< 0.05. N indicates the
number of animals and n indicates the number of cells.
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